Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Murfreesboro, Tennessee


Purpose:

To investigate the effectiveness of the newer IOP-lowering therapies, as prescribed in normal clinical practice, in larger patient numbers. Patients will be assessed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final follow-up visit.


Criteria:

Inclusion Criteria: - A diagnosis of Primary Open-Angle Glaucoma or Ocular Hypertension newly diagnosed OR presenting with insufficiently controlled IOP on current medication (in the opinion of the treating physician) - Patient is having both eyes treated Exclusion Criteria: - Contraindications per product labelling will apply. - Patients with any ophthalmic co-morbidity with an influence on visual field deterioration or optic nerve head damage.


NCT ID:

NCT00716742


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Murfreesboro, Tennessee
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 19, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.